1. Home
  2. VANI vs HGBL Comparison

VANI vs HGBL Comparison

Compare VANI & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • HGBL
  • Stock Information
  • Founded
  • VANI 1998
  • HGBL 1937
  • Country
  • VANI United States
  • HGBL United States
  • Employees
  • VANI N/A
  • HGBL N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HGBL Business Services
  • Sector
  • VANI Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • VANI Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • VANI 69.3M
  • HGBL 81.0M
  • IPO Year
  • VANI 2014
  • HGBL N/A
  • Fundamental
  • Price
  • VANI $1.15
  • HGBL $2.03
  • Analyst Decision
  • VANI Strong Buy
  • HGBL
  • Analyst Count
  • VANI 1
  • HGBL 0
  • Target Price
  • VANI $3.00
  • HGBL N/A
  • AVG Volume (30 Days)
  • VANI 83.2K
  • HGBL 51.8K
  • Earning Date
  • VANI 03-25-2025
  • HGBL 03-13-2025
  • Dividend Yield
  • VANI N/A
  • HGBL N/A
  • EPS Growth
  • VANI N/A
  • HGBL N/A
  • EPS
  • VANI N/A
  • HGBL 0.27
  • Revenue
  • VANI N/A
  • HGBL $49,878,000.00
  • Revenue This Year
  • VANI N/A
  • HGBL N/A
  • Revenue Next Year
  • VANI N/A
  • HGBL $19.47
  • P/E Ratio
  • VANI N/A
  • HGBL $7.50
  • Revenue Growth
  • VANI N/A
  • HGBL N/A
  • 52 Week Low
  • VANI $1.01
  • HGBL $1.52
  • 52 Week High
  • VANI $7.80
  • HGBL $3.09
  • Technical
  • Relative Strength Index (RSI)
  • VANI 43.02
  • HGBL 41.96
  • Support Level
  • VANI $1.12
  • HGBL $2.20
  • Resistance Level
  • VANI $1.19
  • HGBL $2.32
  • Average True Range (ATR)
  • VANI 0.03
  • HGBL 0.09
  • MACD
  • VANI 0.00
  • HGBL -0.03
  • Stochastic Oscillator
  • VANI 42.86
  • HGBL 37.50

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a global full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: